Abstract:Importance: A global outbreak of clade IIb Monkeypox virus (MPXV) infections spread rapidly across at least 118 countries resulting in a Public Health Emergency of International Concern (PHEIC) from July 2022 to May 2023. This outbreak affected more than 99 000 persons worldwide and caused more than 33 000 infections and 60 deaths in the US. In 2024, there have been approximately 200 new infections per month in the US. On August 14, 2024, the World Health Organization declared mpox a PHEIC for a second time due to a rapid increase in infections with clade I MPXV in Central Africa. Observations: Mpox is primarily acquired through direct skin to skin contact with MPXV. With clade IIb MPXV, infections are most commonly associated with sexual activity among individuals who are gay, bisexual, and other men who have sex with men. After a median incubation period of 7 to 10 days, prodromal symptoms include fever (62%-72%), lymphadenopathy (56%-86%), myalgias (31%-55%), malaise (23%-57%), and headache (25%-55%). Skin lesions progress through 4 well-defined stages (macules, papules, vesicles, and pustules) over 2 to 4 weeks. Clade IIb MPXV is typically a self-limited illness with a low mortality rate (<0.2% in the US); however, severe illness and death may occur in immunocompromised individuals, especially those with advanced HIV (CD4 count <200 cells/μL). Mpox should be suspected in patients with potential exposure to MPXV who have skin lesions, and the diagnosis is confirmed with polymerase chain reaction testing of lesions. Management is supportive and focuses on skin care and symptom relief with analgesics. While no antiviral treatments are currently approved for mpox by the US Food and Drug Administration, several therapeutics, such as tecovirimat, brincidofovir, and vaccinia immune globulin intravenous, are available through expanded access programs or clinical trials. Vaccination with the 2-dose Modified Vaccinia Ankara-Bavarian Nordic vaccine is recommended for high-incidence populations and has an efficacy of 66% to 86%. Conclusions and relevance: Mpox is a viral infection transmitted primarily through close skin to skin contact that typically causes a self-resolving illness but can result in severe illness and death in immunocompromised individuals. First-line therapy is supportive care, although patients with severe mpox infection may be treated with advanced therapeutics. Mpox vaccination is effective and, if available, should be offered to individuals at risk of exposure to mpox.

Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art Review

Diagnostic Strategies in the Era of Monkeypox Resurgence: A Comprehensive Analysis

Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit?

The Re-Emergence of Mpox: Old Illness, Modern Challenges

Current and perspective sensing methods for monkeypox virus: a reemerging zoonosis in its infancy

Mpox Virus: Its Molecular Evolution and Potential Impact on Viral Epidemiology

Enhancing Diagnostic Accuracy in Common Human Poxvirus Infections During Mpox Outbreak: A Dermoscopy Review

The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era

Mpox Virus and its ocular surface manifestations

Exploring Monkeypox: prospects for therapeutics through computational-aided drug discovery

Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment

An overview of the progress made in research into the Mpox virus

Mpox: an updated review of dermatological manifestations in the current outbreak

Monkeypox virus: insights into pathogenesis and laboratory testing methods

AI-Based Approaches for the Diagnosis of Mpox: Challenges and Future Prospects

Insights into the Monkeypox virus: making of another pandemic within the pandemic?

Mpox treatment evolution: past milestones, present advances, and future directions

Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review

Breakthrough infection and reinfection in patients with mpox

The Human Monkeypox Virus and Host Immunity: Emerging Diagnostic and Therapeutic Challenges

Insights into the challenging multi-country outbreak of Mpox: a comprehensive review